Oral misoprostol with mifepristone versus misoprostol alone for inducing labor in intrauterine fetal death: A randomized placebo-controlled trial

Context: Intrauterine fetal death (IUFD) causes emotional distress and could result in intrauterine infection. In view of these complications, medical induction is recommended, if it is safe. Aim: The aim of this study was to compare the efficacy and safety of a combination of mifepristone and misop...

Full description

Bibliographic Details
Main Authors: Yazhini Arjunan, Kubera Siddappa Nichanahalli, Veena Pampapati, Dilip Kumar Maurya, Soundara Raghavan Subrahmaniyan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:International Journal of Advanced Medical and Health Research
Subjects:
Online Access:http://www.ijamhrjournal.org/article.asp?issn=2349-4220;year=2017;volume=4;issue=1;spage=23;epage=26;aulast=Arjunan
id doaj-ec9bf5e7a4d34533abbd6d4a58ba94af
record_format Article
spelling doaj-ec9bf5e7a4d34533abbd6d4a58ba94af2020-11-24T21:19:50ZengWolters Kluwer Medknow PublicationsInternational Journal of Advanced Medical and Health Research2349-42202350-02982017-01-0141232610.4103/IJAMR.IJAMR_70_16Oral misoprostol with mifepristone versus misoprostol alone for inducing labor in intrauterine fetal death: A randomized placebo-controlled trialYazhini ArjunanKubera Siddappa NichanahalliVeena PampapatiDilip Kumar MauryaSoundara Raghavan SubrahmaniyanContext: Intrauterine fetal death (IUFD) causes emotional distress and could result in intrauterine infection. In view of these complications, medical induction is recommended, if it is safe. Aim: The aim of this study was to compare the efficacy and safety of a combination of mifepristone and misoprostol with oral misoprostol alone for induction of labor in IUFD. Settings and Design: This is a randomized placebo-controlled trial conducted at a tertiary care teaching hospital in southern India. Patients and Methods: We recruited 72 women with IUFD in a singleton pregnancy after 28 weeks with intact membranes. Thirty-six women received oral placebo followed by misoprostol. In other group, 36 women received 200 mg oral mifepristone followed by misoprostol (both groups received 50 μg orally 4th hourly up to 5 doses). The interval between mifepristone/placebo and the first dose of misoprostol was 24 h. Results: Successful delivery occurred within 72 h in 31 of 36 (86%) women who received mifepristone before misoprostol and in 28 of 36 (78%) women who received only misoprostol (P = 0.541). Median (interquartile range) induction to delivery interval was 3.5 (2–5) and 4 (3–5) h in the combination group and misoprostol group, respectively (P = 0.465). Conclusions: Addition of mifepristone to misoprostol appears to be marginally more effective than misoprostol alone for induction of labor in intermediate and late IUFD, although the differences were not statistically significant.http://www.ijamhrjournal.org/article.asp?issn=2349-4220;year=2017;volume=4;issue=1;spage=23;epage=26;aulast=ArjunanIntrauterine fetal deathmifepristonemisoprostolrandomized controlled trial
collection DOAJ
language English
format Article
sources DOAJ
author Yazhini Arjunan
Kubera Siddappa Nichanahalli
Veena Pampapati
Dilip Kumar Maurya
Soundara Raghavan Subrahmaniyan
spellingShingle Yazhini Arjunan
Kubera Siddappa Nichanahalli
Veena Pampapati
Dilip Kumar Maurya
Soundara Raghavan Subrahmaniyan
Oral misoprostol with mifepristone versus misoprostol alone for inducing labor in intrauterine fetal death: A randomized placebo-controlled trial
International Journal of Advanced Medical and Health Research
Intrauterine fetal death
mifepristone
misoprostol
randomized controlled trial
author_facet Yazhini Arjunan
Kubera Siddappa Nichanahalli
Veena Pampapati
Dilip Kumar Maurya
Soundara Raghavan Subrahmaniyan
author_sort Yazhini Arjunan
title Oral misoprostol with mifepristone versus misoprostol alone for inducing labor in intrauterine fetal death: A randomized placebo-controlled trial
title_short Oral misoprostol with mifepristone versus misoprostol alone for inducing labor in intrauterine fetal death: A randomized placebo-controlled trial
title_full Oral misoprostol with mifepristone versus misoprostol alone for inducing labor in intrauterine fetal death: A randomized placebo-controlled trial
title_fullStr Oral misoprostol with mifepristone versus misoprostol alone for inducing labor in intrauterine fetal death: A randomized placebo-controlled trial
title_full_unstemmed Oral misoprostol with mifepristone versus misoprostol alone for inducing labor in intrauterine fetal death: A randomized placebo-controlled trial
title_sort oral misoprostol with mifepristone versus misoprostol alone for inducing labor in intrauterine fetal death: a randomized placebo-controlled trial
publisher Wolters Kluwer Medknow Publications
series International Journal of Advanced Medical and Health Research
issn 2349-4220
2350-0298
publishDate 2017-01-01
description Context: Intrauterine fetal death (IUFD) causes emotional distress and could result in intrauterine infection. In view of these complications, medical induction is recommended, if it is safe. Aim: The aim of this study was to compare the efficacy and safety of a combination of mifepristone and misoprostol with oral misoprostol alone for induction of labor in IUFD. Settings and Design: This is a randomized placebo-controlled trial conducted at a tertiary care teaching hospital in southern India. Patients and Methods: We recruited 72 women with IUFD in a singleton pregnancy after 28 weeks with intact membranes. Thirty-six women received oral placebo followed by misoprostol. In other group, 36 women received 200 mg oral mifepristone followed by misoprostol (both groups received 50 μg orally 4th hourly up to 5 doses). The interval between mifepristone/placebo and the first dose of misoprostol was 24 h. Results: Successful delivery occurred within 72 h in 31 of 36 (86%) women who received mifepristone before misoprostol and in 28 of 36 (78%) women who received only misoprostol (P = 0.541). Median (interquartile range) induction to delivery interval was 3.5 (2–5) and 4 (3–5) h in the combination group and misoprostol group, respectively (P = 0.465). Conclusions: Addition of mifepristone to misoprostol appears to be marginally more effective than misoprostol alone for induction of labor in intermediate and late IUFD, although the differences were not statistically significant.
topic Intrauterine fetal death
mifepristone
misoprostol
randomized controlled trial
url http://www.ijamhrjournal.org/article.asp?issn=2349-4220;year=2017;volume=4;issue=1;spage=23;epage=26;aulast=Arjunan
work_keys_str_mv AT yazhiniarjunan oralmisoprostolwithmifepristoneversusmisoprostolaloneforinducinglaborinintrauterinefetaldeatharandomizedplacebocontrolledtrial
AT kuberasiddappanichanahalli oralmisoprostolwithmifepristoneversusmisoprostolaloneforinducinglaborinintrauterinefetaldeatharandomizedplacebocontrolledtrial
AT veenapampapati oralmisoprostolwithmifepristoneversusmisoprostolaloneforinducinglaborinintrauterinefetaldeatharandomizedplacebocontrolledtrial
AT dilipkumarmaurya oralmisoprostolwithmifepristoneversusmisoprostolaloneforinducinglaborinintrauterinefetaldeatharandomizedplacebocontrolledtrial
AT soundararaghavansubrahmaniyan oralmisoprostolwithmifepristoneversusmisoprostolaloneforinducinglaborinintrauterinefetaldeatharandomizedplacebocontrolledtrial
_version_ 1726005077503639552